Evaluation status available after sign-in
About the journal
Med is a journal published by Elsevier BV in United States. It is listed in MEDLINE and PUBMED according to the sources read. Declared publication charge: 8,900 USD. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2666-6359 · 2666-6340
- Country
- United States
- Access
- Not open access / not declared
- Declared publication charge
- 8,900 USD
- Declared peer-review model
- peer_review
- Official website
- https://www.sciencedirect.com/journal/med/issues
Index listings
- MEDLINE · 2020-01-01
- PUBMED · 2020-12-18
- Indexing
- MEDLINE · PUBMED
- APC
- 8,900 USD
- Declared review time (DOAJ)
- —
- Actual review time (measured)
- 102 days received→accepted — computed from PubMed (n=100)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
837
Last recorded publication year
2026
Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
65
i10-index
295
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 97%
- ORCID iDs in current deposits
- 61%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101769215
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- SARS-CoV-2 and COVID-19 Research
- Immunotherapy and Immune Responses
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Show all subjects (75)
- CAR-T cell therapy research
- CAR-T cell therapy research
- COVID-19 Clinical Research Studies
- COVID-19 Clinical Research Studies
- CAR-T cell therapy research
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune Cell Function and Interaction
- Lung Cancer Treatments and Mutations
- vaccines and immunoinformatics approaches
- Gut microbiota and health
- vaccines and immunoinformatics approaches
- Gut microbiota and health
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Gut microbiota and health
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- T-cell and B-cell Immunology
- Monoclonal and Polyclonal Antibodies Research
- Monoclonal and Polyclonal Antibodies Research
- Liver Disease Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- COVID-19 epidemiological studies
- Lung Cancer Research Studies
- Liver Disease Diagnosis and Treatment
- CRISPR and Genetic Engineering
- Lung Cancer Research Studies
- Diabetes Treatment and Management
- Lung Cancer Diagnosis and Treatment
- Inflammatory Bowel Disease
- Genomics and Rare Diseases
- Virus-based gene therapy research
- Single-cell and spatial transcriptomics
- SARS-CoV-2 detection and testing
- Long-Term Effects of COVID-19
- Genomics and Rare Diseases
- Single-cell and spatial transcriptomics
- Long-Term Effects of COVID-19
- Virus-based gene therapy research
- Virus-based gene therapy research
- Head and Neck Cancer Studies
- SARS-CoV-2 detection and testing
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Artificial Intelligence in Healthcare and Education
- SARS-CoV-2 detection and testing
- Diabetes Treatment and Management
- Diversity and Career in Medicine
- Diabetes Treatment and Management
- T-cell and B-cell Immunology
- T-cell and B-cell Immunology
- Colorectal Cancer Treatments and Studies
- Immune responses and vaccinations
- Chronic Lymphocytic Leukemia Research
- Multiple Sclerosis Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Inflammatory Bowel Disease
- COVID-19 epidemiological studies
- COVID-19 epidemiological studies
- Inflammatory Bowel Disease
- HIV Research and Treatment
- HIV Research and Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ